Summary
An improved enzyme-linked immunosorbent assay (ELISA) for the detection of anticollagen antibodies in human serum has been developed. With the use of this method, antibodies against native human Type II collagen were detected in 22.7% of sera from 480 patients with rheumatoid arthritis (RA). The antibodies were found to be collagen type specific, showing no reaction with human Type I and Type III collagens. The antibodies appeared in high incidence during the early phase of the disease, and RA patients with involvement of a single joint, mono-articular arthritis, were often positive for anti-Type II collagen antibodies. In most of these patients, anti-Type II collagen antibodies preceded the appearance of rheumatoid factors. The antibodies were all negative in sera from patients with gout, osteoarthritis (OA) and non-arthritic diseases. Thus, anti-Type II collagen antibody assay may have diagnostic significance for RA patients, especially those in whom laboratory and clinical findings provide only minimal help in diagnosis.
Résumé
En vue de détecter des anticorps anti-collagène dans le sérum humain, une technique améliorée du test ELISA a été mise au point. Par cette technique on a détecté dans 22.7% des échantillons rassemblés chez 480 patients atteints d'arthrite rhumatoïde (AR), des anticorps contre le collagène Type II d'origine humaine. Ces anticorps agissent sur un type spécifique de collagène et restent inactifs vis à vis des collagènes naturels d'origine humaine de Type I et III. Les anticorps apparaissent avec une grande fréquence pendant la première phase de la maladie et les patients atteints d'une seule localisation d'AR, c'est à dire d'une monoarthrite, sont souvent positifs aux anticorps anti-collagène Type II. Chez la plupart de ces patients les anticorps anti-collagène Type II ont précédé l'apparition des facteurs rhumatoïdes. D'autre part, on a constaté que ces anticorps ne sont pas présents dans le sérum des patients atteints de goutte, d'ostéo-arthrose et de maladies non arthrosiques. Par conséquent la recherche d'anticorps anti-collagène Type II pourrait jouer un rôle important dans le diagnostic d'AR, en particulier chez les malades pour lesquels l'examen clinique et les examens de laboratoire ne fournissent que peu d'éléments en faveur de ce diagnostic.
Similar content being viewed by others
References
Andripoulos NA, Mcstecky J, Miller EJ, Bradley EL (1976) Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum 19: 613–617
Beard HK, Lca DJ, Ryvar R (1979) Anomalous reactions in the haemagglutination assay for anticollagen antibodies. Studies on patients with rheumatoid arthritis or chronic low back pain. J Immunol Methods 31: 119–128
Beard HK, Ryvar R, Skingle J, Greenbury CL (1980) Anticollagen antibodies in sera from rheumatoid arthritis patients. J Clin Pathol 33: 1077–1081
Clague RB, Shaw MJ, Holt PJL (1980) Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann Rheum Dis 39: 201–206
Ebringer RW, Rook G, Swan GT, Bottazzog F (1981) Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases. Ann Rheum Dis 40: 473–479
Eeckhout Y, Cambiasco CL, Riccomi H, Vaes G, Masson PL (1979) Agglutination of IgG-coated particles by collagen. FEBS Lett 107: 69–72
Epstein EH Jr (1974) [al(III)]3 human skin collagen. Release by pepsin digestion and preponderance in fetal life. J Biol Chem 249: 3225–3231
Foidart JM, Abe S, Martin GR, Zizic T, Barnett EV, Lawley TJ, Katz SI (1978) Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 299: 1203–1207
Fujii K, Tsuji M, Murota K (1986) Isolation of peripheral nerve collagen. Neurochem Res 11: 1439–1446
Fujii K, Tsui M, Murota K, Terato K, Shimozuru Y, Nagai Y (1989) An improved enzyme-linked immunosorbent assay of anti-collagen antibodies in human serum. J Immunol Methods 124: 63–70
Gay S, Ward WQ, Gay R, Miller EJ (1980) Autoantibodies to basement membrane collagen. Epidermolysis bullosa simplex versus bullous pemphigoid. J Cutan Pathol 7: 315–317
Greenbury CL, Skingle J (1979) Anti-cartilage antibody. J Clin Pathol 32: 826–831
Kojev M, Menzel EJ, Smolen JS, Zielinski C (1978) Detection of collagenase in passive haemagglutination using collagen-coated erythrocytes. Klin Wochenschr 90: 733–736
Mackel AM, DeLustro F, Harper F, LeRoy C (1982) Antibodies to collagen in scleroderma. Arthritis Rheum 25: 522–531
McCarty DJ (1972) Methods for evaluating rheumatoid arthritis, arthritis and allied conditions, 8th edn, JL Hollander, DJ McCarty (eds). Lea & Febiger, Philadelphia Jr, pp 419–438
Menzel J, Steffen C, Kolart G, Kojer M, Smolen J (1978) Demonstration of anticollagen antibodies in rheumatoid arthritis synovial fluids by 14C-radioimmunoassay. Arthritis Rheum 21: 243–248
Michaeli D, Fudenberg HH (1974) The incidence and antigenic specificity of antibodies against denatured human collagen in rheumatoid arthritis. Clin Immunol Immunopathol 2: 153–159
Miller EJ (1971) Isolation and characterization of a collagen from chick cartilage containing three identical chains. Biochemistry 10: 1652–1659
Miller EJ (1973) Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin. Biochemistry 11: 4903–4909
Steffen C (1969) Tissue antibodies in rheumatoid arthritis and other connective tissue diseases. Ann Immunol 1: 47–58
Stuart JM, Dixon FJ (1983) Serum transfers of collagen-induced arthritis in mice. J Exp Med 158: 378–392
Stuart JM, Huffstutter EH, Townes AS, Kang AH (1983) Incidence and specificity of antibodies to type I, II, III, IV and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 1251-Radioimmunoassay. Arthritis Rheum 26: 832–840
Suou T, and Hirayama C (1980) Antibodies to denatured bovine collagen in sera of patients with liver disease. Clin Exp Immunol 39: 119–124
Terato K, Hasty KA, Cremer MA, Stuart JM, Townes AS, Kang AH (1985) Collagen-induced arthritis in mice: Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med 162: 637–646
Terato K, Arai H, Shimoruzu Y, Fukuda T, Tanaka H, Watanabe H, Nagai V, Fujimoto K, Okubo F, Cho F, Honjo S, Cremer MA (1989) Sex-linked differences is susceptibility of cynomologus monkeys to type II collagen-induced arthritis: evidence that epitope-specific immune suppression is involved in the regulation of type II collagen autoantibody formation. Arthritis Rheum 32: 748–758
Terato K, Shimozuru Y, Katayama K, Takemitsu Y, Yamashita I, Miyatsu M, Fujii K, Sagara M, Kobayashi S, Goto M, Nishioka K, Miyasaka M, Nagai Y (1990) Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum 33: 1493–1500
Trentham DE, Townes AS, Kang AH (1977) Autoimmunity to type II collagen: An experimental model of arthritis. J Exp Med 146: 857–868
Watson WC, Cremer MA, Wooley PH, Townes AS (1986) Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted 1gG 3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum 29: 1316–1321
Yoo TJ, Stuart JM, Kang AH, Townes AS, Tomoda K, Dixit S (1982) Type II collagen autoimmunity in otosclerosis and Menière's disease. Science 217: 1153–1155
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujii, K., Tsuji, M., Kitamura, A. et al. The diagnostic significance of anti-Type II collagen antibody assay in rheumatoid arthritis. International Orthopaedics 16, 272–276 (1992). https://doi.org/10.1007/BF00182710
Issue Date:
DOI: https://doi.org/10.1007/BF00182710